AMA Backs Structured Vaccine Review
-
By
February 11, 2026
-
4 min
-
1
New initiative by AMA and Vaccine Integrity Project for vaccine assessment.
-
2
Focus on influenza, COVID-19, and RSV vaccines for 2026-
-
3
Structured review process will include expert panels.
-
4
Emphasis on evidence-based immunization guidance.
-
5
Addressing concerns over ACIP's effectiveness.
-
6
Transparency and conflict of interest disclosures required.
-
7
Aimed at restoring clinician and patient confidence in vaccines.
-
A new initiative by the American Medical Association (AMA) and the Vaccine Integrity Project aims to assess the safety and effectiveness of influenza, COVID-19, and RSV vaccines for the 2026-2027 season. This comes in response to concerns over the current state of vaccine recommendation practices following the dismissal of ACIP members. The structured review process will involve expert panels, systematic literature reviews, and transparent public protocols. The goal is to restore trust in vaccine recommendations through evidence-based guidance for various population groups.
-
1
New initiative by AMA and Vaccine Integrity Project for vaccine assessment.
-
2
Focus on influenza, COVID-19, and RSV vaccines for 2026-
-
3
Structured review process will include expert panels.
-
4
Emphasis on evidence-based immunization guidance.
-
5
Addressing concerns over ACIP's effectiveness.
-
6
Transparency and conflict of interest disclosures required.
-
7
Aimed at restoring clinician and patient confidence in vaccines.
Listen Tab content
